NASDAQ:MIRM

Mirum Pharmaceuticals Stock Forecast

etoro logo Buy MIRM
*Your capital is at risk
$111.07
+3.30 (+3.06%)
At Close: Jun 23, 2026
AI Analysis AI Analysis of MIRM AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add MIRM to Watchlist?
Some Reasons Why To Add MIRM:
  • +117.3% price growth over the last year
  • High gross margin of 81.4%
  • Bullish trend confirmed on both short and long timeframes
PDF

Mirum Pharmaceuticals, Inc. stock price ended at $111.07 on Tuesday, after gaining 3.06%
(Updated on Jun 23, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy candidate since Jun 11, 2026 Gain 11.58%

The Mirum Pharmaceuticals, Inc. stock price gained 3.06% on the last trading day (Tuesday, 23rd Jun 2026), rising from $107.77 to $111.07. It has now gained 6 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 5.81% from a day low at $105.25 to a day high of $111.36. The price has risen in 8 of the last 10 days and is up by 18.68% over the past 2 weeks. Volume fell on the last day by -133 thousand shares and in total, 1 million shares were bought and sold for approximately $119.25 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the upper part of a wide and weak rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $115.27 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 8.73% during the next 3 months and, with a 90% probability hold a price between $101.96 and $125.33 at the end of this 3-month period.

MIRM Signals & Forecast

Mostly positive signals in the chart today. The Mirum Pharmaceuticals, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $104.27 and $100.89. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 03, 2026, and so far it has risen 20.95%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.

Support, Risk & Stop-loss for Mirum Pharmaceuticals, Inc. stock

Mirum Pharmaceuticals, Inc. finds support from accumulated volume at $109.16 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $6.12 between high and low, or 5.81%. For the last week, the stock has had daily average volatility of 3.78%.

The Mirum Pharmaceuticals, Inc. stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs. Since the Mirum Pharmaceuticals, Inc. has been rising for 6 days in a row, the risk over the next couple of days has increased. We don't expect a major reaction as the stock is in very good shape technically, and therefore hold a positive evaluation despite the very short term risk.

Our recommended stop-loss: $108.09 (-2.68%) (This stock has medium daily movements and this gives medium risk. The RSI14 is 91 and this increases the risk substantially. There is a buy signal from a pivot bottom found 13 days ago.)

Trading Expectations (MIRM) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Mirum Pharmaceuticals, Inc. to open at $109.23, and during the day (based on 14 day Average True Range), to move between $108.73 and $113.41, which gives a possible trading interval of +/-$4.68 (+/-4.31%) up or down from last closing price. If Mirum Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 4.31% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $111.39 (0.29%) than the support at $109.16 (1.72%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Mirum Pharmaceuticals, Inc. stock A Buy?

Mirum Pharmaceuticals, Inc. holds several positive signals and is within a weak rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.

Current score: 7.059 Strong Buy Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $109.23 ( 1.66%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

MIRM Performance

Trading levels for MIRM

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 115.34 3.84%
R2 113.00 1.74%
R1 111.56 0.442%
Price 111.07
S1 106.89 -3.76%
S2 105.45 -5.06%
S3 103.11 -7.17%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 111.39 0.288%
Price 111.07
S1 109.16 -1.72%
S2 105.79 -4.75%
S3 102.93 -7.33%

FAQ

What is the symbol for Mirum Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for Mirum Pharmaceuticals, Inc. is MIRM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Mirum Pharmaceuticals, Inc. Stock?
Mirum Pharmaceuticals, Inc. holds several positive signals and is within a weak rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.

How to buy Mirum Pharmaceuticals, Inc. Stock?
Mirum Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Mirum Pharmaceuticals, Inc. Stock.

What's the current price of Mirum Pharmaceuticals, Inc. Stock?
As of the end of day on the Jun 23, 2026, the price of an Mirum Pharmaceuticals, Inc. (MIRM) share was $111.07.

What is the 52-week high and low for Mirum Pharmaceuticals, Inc. Stock?
The 52-week high for Mirum Pharmaceuticals, Inc. Stock is $114.99 and the 52-week low is $47.89.

What is the market capitalization of Mirum Pharmaceuticals, Inc. Stock?
As of the Jun 23, 2026, the market capitalization of Mirum Pharmaceuticals, Inc. is 5.576B.

When is the next earnings date for Mirum Pharmaceuticals, Inc.?
The upcoming earnings date for Mirum Pharmaceuticals, Inc. is Jul 30, 2026.
Click to get the best stock tips daily for free!
ABOUT MIRUM PHARMACEUTICALS, INC.
Mirum Pharmaceuticals
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment o...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
20.46% Jun 12
DHI
$146.71
6.39% Jun 10
EAT
$140.46
16.94% Jun 05
E
ETD
$20.67
4.79% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE